1.
Record response to call for new astronauts
WASHINGTON, Jan. 26 (UPI) -- The U.S. Food and Drug Administration says it has approved Victoza, a once-daily injection to treat type 2 diabetes in some adults.
The FDA said Victoza (liraglutide) is intended to help lower blood sugar levels along with diet, exercise and selected other diabetes medicines. It is not recommended as initial therapy in patients who have not achieved adequate diabetes control on diet and exercise alone. Victoza is in a class of medicines that help the pancreas make more insulin after eating a meal.
"Controlling blood sugar levels is very important to preventing or reducing the long-term complications of diabetes, and Victoza offers certain patients with type 2 diabetes a treatment option for controlling their blood glucose levels," said Dr. Mary Parks, director of the FDA's division of metabolism and endocrinology products.
Victoza is manufactured by Novo Nordisk of Bagsvaerd, Denmark.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, Feb. 10 (UPI) --
A woman who says she had an affair with President John F. Kennedy wrote that she didn't feel at the time she was "invading the Kennedys' marriage."
|
LOS ANGELES, Feb. 10 (UPI) --
Pop icon Madonna says she "wasn't happy" after rapper M.I.A. flipped her middle finger at a camera during their Super Bowl halftime show.
|
ST. PETERSBURG, Russia, Feb. 10 (UPI) --
A water sample from Lake Vostok, hidden under Antarctic ice for millions of years, has been presented to Russia's Prime Minister Vladimir Putin, scientists say.
|
BIRMINGHAM, England, Feb. 10 (UPI) --
A British company said it is opening salons across England dedicated to the tattooing the scalps of bald men to make it look like they have short hair.
|
| Stories | Photos | People | Comments |
View Caption
